Glorious Chain Marketing
FDA import alert and refusal historyPasig, PhilippinesFEI 3008600250
Recorded by FDA as GLORIOUS CHAIN MARKETING
As of October 26, 2026, Glorious Chain Marketing (Pasig, Philippines) is on the red list of FDA Import Alert 45-02 (Foods with illegal or undeclared colors) for royal tru-orange beverage, published by FDA on August 17, 2012, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 45-02 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Glorious Chain Marketing
1 record, newest first. Each line links to the FDA page it came from.
2012
- Import alert listingListed on Import Alert 45-02red listRoyal Tru-Orange BeverageSource
Questions about Glorious Chain Marketing
- Is Glorious Chain Marketing on an FDA import alert?
- Yes. As of October 26, 2026, Glorious Chain Marketing is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for royal tru-orange beverage; FDA published the listing on August 17, 2012.
- Has FDA refused shipments from Glorious Chain Marketing?
- No FDA import refusals for Glorious Chain Marketing appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Glorious Chain Marketing's FEI number?
- Glorious Chain Marketing's FDA Establishment Identifier (FEI) is 3008600250.
- Can shipments from Glorious Chain Marketing still enter the U.S.?
- Shipments of royal tru-orange beverage from Glorious Chain Marketing can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Glorious Chain Marketing?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.